The overarching goal of this well-established training program, which entered its 30th year in May 2013, is to maintain and accelerate long term research progress and innovation in cutaneous biology, skin diseases, and dermatoepidemiology, leading to novel treatments for skin disease and improvements in overall human health.
We aim to achieve this by identifying and training the next generation of leaders in this area. Our specific goals are to: (i) expose trainees to the excitement and impact of dermatology research at early stages in their careers;(ii) support the research and training of young scientists with established interests in the skin and its diseases;and (iii) provide cross-disciplinary training in skin biology and diverse fields such as genomics, epidemiology or bioengineering. To these ends we request support for short term (2-3 months) research experiences for 3 medical students;2 long term (1 year or more) pre-doctoral fellowships to support the thesis research of MD PhD students, PhD students engaging in innovative, interdisciplinary work relevant to cutaneous biology and skin disease, or students pursuing dual MD and Masters in Clinical Epidemiology (MSCE) degrees;and 4 post-doctoral fellowships for MD, PhD and MD PhD scientists committed to careers in cutaneous biology and skin disease. To promote interdisciplinary research, our program involves trainers from the Penn Engineering School, the School of Veterinary Medicine, and the Wistar Institute as well as from Dermatology and multiple other departments across the Penn School of Medicine, and includes experts in clinical studies, bioengineering, proteomics and genomics research. A particular emphasis of our training program is to encourage and train physician scientists in Dermatology. In addition to training MD and MD PhD students in skin-related research, we established a four-year clinical/research dermatology residency program in which trainees pursue T32-supported postdoctoral research fellowships that provide a basis for obtaining independent funding. This program has already been extremely successful, attracting exceptionally qualified, enthusiastic trainees, several of whom are now established as NIH-funded independent physician-scientists. Our training program includes opportunities for lab-based research, translational research, clinical trials, and epidemiology. In parallel with "hands on" research training, our trainees atted seminars, journal clubs and technical and skills workshops both within and outside Dermatology. We provide networking lunches and research retreats for trainees, and trainees invite two seminar speakers per year to present their research in the Dermatology Seminar Series, followed by lunch with the speaker. Trainees receive formal instruction in the Responsible Conduct of Research, and extensive mentoring, career counseling, and help in identifying suitable positions in academics, industry, or for further training in clinical or reseach areas from the Director and co- Director of the training program as well as from their mentors and, in the case of MD PhD and PhD thesis students, their home Graduate Programs.

Public Health Relevance

Skin diseases are extremely prevalent, represent a significant health burden, and are increasingly recognized as predisposing individuals to systemic conditions such as inflammatory diseases and heart disease. The goal of this training program is to identify and train the next generation of leaders in cutaneous biology, skin diseases, and dermatoepidemiology, in order to maintain and accelerate long term research progress and innovation in this area and promote the development of novel treatments for skin disease and improvements in overall human health.

Agency
National Institute of Health (NIH)
Type
Institutional National Research Service Award (T32)
Project #
2T32AR007465-31
Application #
8667087
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Program Officer
Baker, Carl
Project Start
Project End
Budget Start
Budget End
Support Year
31
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Dermatology
Type
Schools of Medicine
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Cho, Michael Jeffrey; Ellebrecht, Christoph T; Payne, Aimee S (2015) The dual nature of interleukin-10 in pemphigus vulgaris. Cytokine 73:335-41
Takeshita, Junko; Callis Duffin, Kristina; Shin, Daniel B et al. (2014) Patient-reported outcomes for psoriasis patients with clear versus almost clear skin in the clinical setting. J Am Acad Dermatol 71:633-41
Chung, Jina; Callis Duffin, Kristina; Takeshita, Junko et al. (2014) Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasis. J Am Acad Dermatol 71:623-32
Noti, Mario; Kim, Brian S; Siracusa, Mark C et al. (2014) Exposure to food allergens through inflamed skin promotes intestinal food allergy through the thymic stromal lymphopoietin-basophil axis. J Allergy Clin Immunol 133:1390-9, 1399.e1-6
Kim, Brian S; Wang, Kelvin; Siracusa, Mark C et al. (2014) Basophils promote innate lymphoid cell responses in inflamed skin. J Immunol 193:3717-25
Cho, Michael Jeffrey; Lo, Agnes S Y; Mao, Xuming et al. (2014) Shared VH1-46 gene usage by pemphigus vulgaris autoantibodies indicates common humoral immune responses among patients. Nat Commun 5:4167
Chu, Derek H; Castelo-Soccio, Leslie; Wan, Joy et al. (2014) Retrospective analysis of beta-blocker instituted for treatment of hemangiomas (RABBIT study). Clin Pediatr (Phila) 53:1084-90
Callis Duffin, K; Yeung, H; Takeshita, J et al. (2014) Patient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practice. Br J Dermatol 170:672-80
Takeshita, Junko; Wang, Shuwei; Shin, Daniel B et al. (2014) Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical setting. J Am Acad Dermatol 71:1167-75
Yeung, Howa; Takeshita, Junko; Mehta, Nehal N et al. (2013) Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol 149:1173-9

Showing the most recent 10 out of 71 publications